Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

BACKGROUND: HBeAg-negative chronic hepatitis B patients require long-term nucleos(t)ide analogues(NAs) because loss of surface antigen (HBsAg) is unusual. Low quantitative HBsAg (qHBsAg) levels can identify patients with higher probability of seroclearance. The aim of our study was to evaluate qHBsA...

Descripción completa

Detalles Bibliográficos
Autores principales: Broquetas, Teresa, Garcia-Retortillo, Montserrat, Hernandez, Juan José, Puigvehí, Marc, Cañete, Nuria, Coll, Susana, Cabrero, Beatriz, Giménez, Maria Dolors, Solà, Ricard, Carrión, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708657/
https://www.ncbi.nlm.nih.gov/pubmed/29190670
http://dx.doi.org/10.1371/journal.pone.0188303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708657/
https://www.ncbi.nlm.nih.gov/pubmed/29190670
http://dx.doi.org/10.1371/journal.pone.0188303

Ejemplares similares